Tuesday Aug 26
Vivus acquires patent rights to Qsymia ingredient
Vivus has acquired a group of patents covering one of the main ingredients behind its weight loss drug Qsymia from Janssen Pharmaceuticals.
Tuesday Aug 26
ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.
ViaCyte, Inc., a privately held regenerative medicine company announced that it has entered into a Rights Agreement with Janssen Research & Development LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Mon Aug 25, 2014
Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs
Johnson & Johnson is appreciating a decent time in 2014, liking 10% and beating the more extensive market so far.
Mon Aug 18, 2014
The Motley Fool
3 Reasons Johnson & Johnson Stock Could Rise
For the quarter, Johnson & Johnson delivered impressive revenue growth of 9.1% year-over-year.
Wed Aug 13, 2014
Check Your Mental Health With Just A Press Of A Button
Philadelphia residents can now check their mental health in the grocery store, thanks to an interactive screening kiosk known as "Checkup and Checkout" that officials unveiled earlier this month.
Fri Aug 08, 2014
Hysterectomy tool creates cancer fears
About 600,000 hysterectomies are performed in the U.S. each year. Research suggests about 40% are done to remove presumably benign or noncancerous fibroids that are causing heavy bleeding, pelvic pressure or pain or other symptoms Power morcellators, like the one below, are used in this procedure, are under scrutiny.
Mon Aug 04, 2014
Outpatient Surgery Magazine
Johnson & Johnson Asks Customers to Return Morcellators
As the polarized debate regarding the safety and desirability of power morcellation in minimally invasive hysterectomies continues to rage, Johnson & Johnson, easily the largest manufacturer of laparoscopic morcellators, has announced that it's withdrawing the device from the market.
Thu Jul 31, 2014
Wall Street Journal
Johnson & Johnson Partners with CircleUp for Early Look at Startups
CircleUp COO Rory Eakin and CEO Ryan Caldbeck with an array of products made by companies that raised equity funding on their site.
Wed Jul 30, 2014
Hysterectomy device pulled off market
Hysterectomy device pulled off market Johnson & Johnson announces worldwide withdrawal of all its laparoscopic power morcellators.